Fund Holdings — Bain Capital Life Sciences Investors, LLC

Total Portfolio Value:
$1.49B
Total Bought:
$327.25M
Total Sold:
$134.88M
Net Transaction:
+$192.37M
Securities
▲▼
SharesValue
Q2 2026
▲▼
Q3 2026
▲▼
Change
▲▼
Q2 2026
▲▼
Q3 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Kailera Therapeutics Inc22,583,26822,583,2680$497.51M$257.90M17.31%-$239.61M
Heartflow, Inc.(HTFL)8,448,1584,448,158-4,000,000$247.87M$221.30M14.85%-$26.57M
Adarx Pharmaceuticals Inc06,728,970+6,728,970$0$134.18M9.01%+$134.18M
Alkermes plcSHS(ALKS)1,937,9383,150,985+1,213,047$101.54M$127.68M8.57%+$26.14M
Newamsterdam Pharma Company
ORDINARY SHARES
3,806,5663,806,559-7$129.00M$92.58M6.21%-$36.43M
Savara Inc.(SVRA)17,600,62117,600,6210$108.42M$90.82M6.10%-$17.60M
Tarsus Pharmaceuticals, Inc.(TARS)01,096,141+1,096,141$0$86.17M5.78%+$86.17M
Pharvaris N V
COM
2,675,5092,475,509-200,000$92.52M$76.92M5.16%-$15.60M
Solid Biosciences Inc9,808,8199,808,8190$97.99M$70.92M4.76%-$27.07M
Olema Oncology, Inc.(OLMA)7,085,2497,085,2490$88.64M$61.22M4.11%-$27.42M
Hemab Therapeutics Holdings Inc1,650,0001,650,0000$60.60M$50.89M3.42%-$9.72M
Cabaletta Bio, Inc.(CABA)17,241,44521,209,188+3,967,743$53.62M$40.72M2.73%-$12.90M
Freenome Inc02,365,459+2,365,459$0$37.26M2.50%+$37.26M
Dyne Therapeutics, Inc.(DYN)01,900,000+1,900,000$0$30.61M2.05%+$30.61M
C4 Therapeutics, Inc.(CCCC)7,171,9107,171,9100$33.49M$23.88M1.60%-$9.61M
X4 Pharmaceuticals, Inc.(XFOR)7,967,4547,967,4540$37.21M$23.11M1.55%-$14.10M
Annexon, Inc.(ANNX)4,437,7314,437,7310$25.34M$18.77M1.26%-$6.57M
Atea Pharmaceuticals, Inc.(AVIR)2,075,6392,075,6390$9.65M$10.81M0.73%+$1.16M
Disc Medicine, Inc.(IRON)141,234141,2340$10.33M$9.25M0.62%-$1.08M
Kyverna Therapeutics, Inc.(KYTX)2,885,0001,312,000-1,573,000$25.71M$8.92M0.60%-$16.78M
Rapid Micro Biosystems, Inc.CL A(RPID)8,434,5608,434,5600$14.59M$8.69M0.58%-$5.90M
Xilio Therapeutics, Inc.(XLO)664,021664,0210$6.36M$6.01M0.40%-$351.9K
Newamsterdam Pharma CompanyW EXP 99 99 999
*W EXP 99/99/999
99,99999,9990$2.14M$1.26M0.08%-$872.0K
Dianthus Therapeutics, Inc.(DNTH)362,4700-362,470$35.33M$0—-$35.33M
Upstream Bio, Inc.(UPB)600,9490-600,949$4.16M$0—-$4.16M
Page 1 of 1
Bain Capital Life Sciences Investors, LLC — 13F Holdings — Q3 2026 | TickerTrail